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Dialectical Behavior Therapy (DBT) is a comprehensive intervention for the treatment of 
borderline personality disorder (BPD), which is characterized by significant emotion 
dysregulation and associated parasuicidal behaviors. Findings from 21 randomized-controlled 
trials indicated that DBT is effective in the treatment of BPD symptoms. While effective, some 
individuals do not obtain symptoms reductions after completing DBT. The aim of the current 
study was to identify factors that predict treatment response among adolescent females (N = 107) 
receiving DBT in a residential setting. It was hypothesized that residents with elevated scores of 
emotion regulation difficulties, intolerance of uncertainty, experiential avoidance, social anxiety 
symptoms, and PTSD-related symptoms would show less improvement of BPD symptoms. On 
average, there were no significant predictors to response to DBT. The results showed that 
irrespective of pre-treatment clinical predictors, DBT was effective, on average, in reducing 
clinical outcome symptoms for approximately half of the sample: 55% of the residents showed 
reliable change (RC) from pre-treatment to post-treatment, 41% showed no RC, and 3% showed 
RC toward deterioration. Further, 22% of the residents in the current study showed clinically 
significant change, meaning that their post-treatment outcome scores would indicate symptom 
remission. None of the study predictors were able to predict whether a resident showed clinically 
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significant change or no clinically significant change at post-treatment. Limitations and future 
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Dialectical Behavior Therapy (DBT) is an evidenced-based cognitive behavioral 
treatment that was originally developed to treat chronically suicidal women who were 
unresponsive to standard cognitive-behavioral intervention (Linehan, Armstrong, Suarez, 
Allmon, & Heard, 1991), and later evolved into a treatment for borderline personality disorder 
(BPD; Linehan, 1993a; 1993b). The word dialectic refers to the belief that two opposing ideas 
can be true at the same time, and a dialectic approach to therapy searchers for the synthesis 
between opposite forces. For instance, DBT therapists are deliberate in their use of acceptance 
(e.g., mindfulness, validation) and change (e.g., problem solving, cognitive restricting) strategies.  
Empirical Support of DBT for BPD 
To date there are at least 20 randomized controlled trials of DBT for BPD (see Linehan, 
Dimeff, Koerner, & Miga, 2014) and several reviews (Bloom, Woodward, Susmaras, & 
Pantalone, 2012; Lynch, Trost, Salsman, & Linehan, 2007; Panos, Jackson, Hasan, & Panos, 
2014; Robins & Chapman, 2004). Together, the results are robust and provide strong support of 
DBT as a treatment for BPD that reduces self-harm and suicide-related behaviors. DBT is 
currently listed as an empirically supported treatment for BPD by Division 12 of the American 
Psychological Association. 
Support is also growing for the use of DBT to treat BPD and co-occurring psychiatric 
disorders, including substance use disorder (DBT-SUD; Axelrod, Perepletchikova, Holtzman, & 
Sinha, 2010; Dimeff & Linehan, 2008), eating disorders (Chen, Matthews, Allen, Kuo, & 
Linehan, 2008; Lynch, et al., 2013; Palmer et al., 2003; Telsh, Agras, & Linehan, 2001), post-
traumatic stress disorder (Harned & Linehan, 2008; Harned, Korslund, Foa, & Linehan, 2012; 
Steil, Dyer, Priebe, Kleindienst, & Bohus, 2011), and transdiagnostic emotion regulation 





The effectiveness of DBT to treat adult population prompted the developed of DBT to 
treat adolescents with BPD-like symptoms. DBT was adapted to treat adolescents (DBT-A; 
Miller, Rathus, Linehan, Wetzler, & Leigh, 1997; Miller, 1999; Rathus & Miller, 2000) in the 
following ways. First, the duration of DBT-A was shortened by reducing the number of DBT 
skills. This was done in an effort to increase retention of adolescents in treatment and reduce 
financial burden of treatment. There is no standardized length of time that DBT-A is completed; 
although, a 16-week format has been proposed (Miller, Rathus, & Linehan, 2007). Second, 
caregivers are asked to join DBT skills groups. Incorporating caregivers into skills group is 
intended to reduce maladaptive environmental barriers (e.g., arguments, “invalidating 
environment”). Third, the language and layout of DBT training materials (e.g., handouts, diary 
cards) were simplified for DBT-A in consultation with Dr. Linehan. Fourth, DBT-A organized 
DBT skills into five modules instead of four. The additional module is called Middle Path and 
includes validation, dialectical thinking, and behavioral skills, which are part of the current “core 
skills” of Interpersonal Effectiveness module of the adult manual. The Middle Path module is 
aimed to help adolescents and their caregivers resolve conflict more effectively. 
While there is some disagreement about diagnosing BPD in adolescents (Chanen & 
McCutcheon, 2008), increasing evidence suggests that diagnosis of BPD in adolescents is as 
reliable and valid as diagnosis of BPD in adults (Chanen, Jovev, McCutcheon, Jackson, & 
McGorry, 2008; Kaess, Brunner & Chanen, 2014; Miller, Muehlenkamp, & Jacobson, 2008). 
Irrespective of BPD diagnosis, among young people aged 15 to 24, suicide remains a major 
health concern and was the second leading cause of death in 2016 with 5,723 deaths (Centers for 




19.8% and 24% (Cha et al., 2017; Nock et al., 2008). Trends of suicide-related behaviors and 
deaths have increased since 2010, with the greatest increases among adolescent females 
(Twenge, Joiner, Rogers, & Martin, 2018). 
Research of DBT-A has grown significantly since the first trial of DBT-A was conducted, 
and the data suggests that DBT-A is effective for treating BPD-like symptoms in adolescents 
(MacPherson, Cheavens, & Fristad, 2013; McCredie, Quinn, & Covington, 2017). DBT-A has 
been employed in different treatment settings, including inpatient hospitalization (Katz & Cox, 
2002; McDonell et al., 2010; Swenson, Sanderson, Dulit, & Linehan, 2001), residential 
hospitalization (McCredie et al., 2017; Wasser, Tyler, McIlhaney, Taplin, & Henderson, 2008), 
partial hospitalization (Memel, 2012), and outpatient (James, Winmill, Anderson, & Alfoadari, 
2011; Rathus & Miller, 2002; Woodberry & Popenoe, 2008). A review of DBT-A supports the 
use of DBT-A in reducing BPD symptomatology, suicidal ideation and comorbid depression, and 
hospitalizations for adolescents across treatment settings (Groves, Backer, van den Bosch, & 
Miller, 2012).   
Treatment Predictors of DBT 
While the findings of DBT clinical trials are robust and show that DBT provides 
significant symptom reductions, DBT does not work for all individuals (Rizvi, 2011), and 25% 
or more of adults enrolled in a trial tend to drop out prematurely (Linehan et at. 2006; McMain et 
al., 2009; Steuwe, Berg, Driessen, Beblo, 2017). Kröger, Harbeck, Armbrust, and Kliem (2013) 
examined data from 1,423 individuals with BPD who were admitted to a 3-month inpatient unit 
conducing DBT. They found that 45% of patients responded to DBT, 30.6% remained 
unchanged, 11.0% deteriorated, and 10% dropped out, highlighting the need for research that 




of DBT may prove fruitful. Identification of treatment predictors of DBT can promote clinical 
gains for individuals receiving DBT and providers delivering DBT. In turn, fewer resources may 
be needed to obtain meaningful clinical outcome.  
Several studies have been conducted to identify factors associated with premature 
dropout of DBT and/or treatment response of DBT among adults. Factors associated with 
premature DBT dropout included low education level (Perroud, Uher, Dieben, Nicastro, & 
Huguelet, 2010), higher levels of baseline experiential avoidance, higher trait anxiety, fewer past 
suicide attempts (Rüsch et al., 2008), a lack of motivation (Soler et al., 2008), substance use 
disorder, younger age at pre-treatment (Kröger et al., 2013) childhood neglect (Steuwe, Berg, 
Driessen, & Beblo, 2017), higher anger, poorer therapeutic alliance, higher number of life-time 
suicide attempts, and greater Axis I comorbidity (Wnuk et al., 2013). Factors not associated with 
premature DBT dropout include length of hospitalizations, severity of BPD symptoms, comorbid 
diagnoses, and socio-economic status (Barnicot, Katsakou, Marougka, & Priebe, 2011). Factors 
related to poor treatment response (as indicated by self-report measures) to DBT include schizoid 
features, low narcissistic traits, a second course of treatment (Perroud et al., 2010), higher 
baseline levels of depression, more emergency department visits, and higher unemployment 
(McMain et al., 2017).  
In summary, DBT is an effective treatment for adults and adolescents with BPD or BPD-
like symptoms. DBT can be applied in different health care setting, and for different psychiatric 
concerns. However, opportunity remains to increase the effectiveness of DBT, and more research 
is needed to identify factors that contribute to treatment response.  
Therefore, the current study investigated potential treatment predictors of DBT. The 




and clinical experience: (1) difficulty regulating emotions, (2) intolerance of uncertainty, (3), 
experiential avoidance, (4) social anxiety symptoms, and (5) trauma symptoms. 
Emotion dysregulation. 
Thompson (1994) defined emotion regulation as ‘the extrinsic and intrinsic processes 
responsible for monitoring, evaluating, and modifying emotional reactions, especially their 
intensive and temporal features, to accomplish one’s goals.’ An inability to effectively regulate 
emotions often leads to experiences of emotion dysregulation, which is a central feature across a 
range of psychiatric symptoms including depression (Jormann & Gotlib, 2010), anxiety (Mennin, 
Heimberg, Turk, & Fresco, 2002), PTSD (Tull, Barrett, McMillan, & Roemer, 2007), substance 
use (Fox, Axelrod, Paliwal, Sleeper, & Sinha, 2007), and nonsuicidal self-injury (Gratz and 
Roemer, 2008; McKenzie & Gross, 2013). Emotion dysregulation is also core to 
conceptualizations of BPD (Glenn & Klonsky, 2009), including Linehan’s biosocial model of 
BPD (1993a). Linehan’s model posits that BPD symptoms arise from a transaction between a 
biological vulnerability of the emotion regulation system (high emotional sensitivity, high 
emotional reactivity, and slow return to emotional baseline) and an invalidating environment. 
DBT skills are aimed to increase one’s ability to regulate emotions, thus reducing BPD 
symptoms. While emotion dysregulation is a target of DBT and a likely mechanism of change  
(Gratz, Levy, & Tull, 2012), it is unclear how pre-treatment levels of emotion regulation 
difficulties affect DBT outcome.  
Intolerance of uncertainty. 
Intolerance of uncertainty is characterized by significant distress resulting from 
ambiguity of a future event that has the possibility of a negative outcome regardless of the 




generalized anxiety disorder and obsessive-compulsive disorder (Dugas, Gosselin, & Ladouceur, 
2001; Wilhelm & Steketee, 2006). However, there is growing evidence in adult populations that 
intolerance of uncertainty is a transdiagnostic feature across multiple disorders (Boswell, 
Thompson-Hollands, Farchione, & Barlow, 2013; Carleton et al., 2012; Gentes & Ruscio, 2011), 
including depression (Yook, Kim, Suh, & Lee, 2010), social anxiety (Boelen & Reijntjes, 2009; 
Carleton, Collimore, & Asmundson, 2010), eating disorders (Sternheim, Startup, & Schmidt, 
2011), and serves as a mechanism of change (McEvoy & Mahoney, 2012). Research of 
adolescents also supports a strong relationship between intolerance of uncertainty and anxiety 
symptoms, including anxiety sensitivity and health anxiety (Wright, Adams, Lebell, & Carleton, 
2016).  
Because intolerance of uncertainty is present in many disorders that are characterized by 
negative affect, it is likely present among individuals with BPD who show high comorbidity with 
disorders of negative affect (Grant et al, 2008). Research of intolerance of uncertainty within the 
context of DBT is important. Given that DBT is a behavioral treatment that requires individuals 
to learn and apply new skills, individuals higher in intolerance of uncertainty may not engage in 
treatment as much as someone lower in intolerance of uncertainty, thus hindering beneficial 
outcome. However, there is no known research that has examined the effect of intolerance of 
uncertainty as a treatment predictor of DBT. 
 Experiential avoidance. 
Experiential avoidance is characterized by a broad range of maladaptive behaviors that 
individuals use to avoid distressing experiences. Hayes and colleagues (2004, p. 554) describe 
experiential avoidance as “a phenomenon that occurs when a person is unwilling to remain in 




memories, images, behavioral predispositions) and takes steps to alter the form or frequency of 
these experiences or the contexts that occasion them, even when these forms of avoidance cause 
behavioral harm.” In BPD, experiential avoidance is associated with BPD symptoms including 
deliberate self-harm, which often functions to avoid negative emotions (Chapman, Gratz, & 
Brown, 2006; Hulbert & Thomas, 2010; Rosenthal et al., 2005).  
Many of the DBT skills require an individual to experience difficult emotions and 
sensations in order to replace ineffective coping strategies (e.g., dissociation, self-harm, self-
invalidation) with more effective coping strategies (e.g., mindfulness, distress tolerance). 
Avoidance of internal experiences may be a barrier to fully engaging in treatment, potentially 
hindering treatment effects. Rüsch and colleagues (2008) found that among 60 adult women 
receiving inpatient DBT, premature dropout was associated with higher levels of experiential 
avoidance than lower levels among completers than non-completers. Experiential avoidance is 
also associated with less improvement of depressive symptoms over psychological treatment 
(Berking, Neacsiu, Comtois, & Linehan, 2009). To date, it appears that no published studies have 
examined the association between EA and treatment outcomes for adolescents with BPD. To 
further our understanding of role of experiential avoidance in DBT, it is important to examine the 
relationship between experiential avoidance on BPD symptoms. 
Co-occurring psychiatric symptoms. 
 Social anxiety symptoms. 
Social anxiety disorder is characterized by a significant fear and avoidance of social 
interactions where evaluation (generally negative) is possible. Individuals with social anxiety 
symptoms may fear specific situations (e.g., public speaking, attending a party) or most 




self) and behaviorally (e.g., avoidance). These symptoms, when present among DBT clients may 
be problematic given that DBT skills are taught in a group setting, thus potentially limiting skills 
acquisition and generalization. 
People who report social anxiety symptoms (without BPD symptoms) are more likely to 
benefit from treatment for social-anxiety symptoms when the therapy is conducted individually 
rather than in group settings (Stangier, Heidenreich, Peitz, Lauterbach, and Clark 2003). Dimeff, 
Rizvi, Brown, and Linehan (2000) conducted a pilot study to test the efficacy of DBT in treating 
with co-morbid BPD and methamphetamine -dependence. They reported that one-third of the 
sample met criteria for social anxiety disorder, and these individuals did not respond as well to 
treatment compared to individuals without social anxiety disorder. Dimeff and colleagues (2000) 
found success in treating social anxiety symptoms prior to individuals starting DBT skills group.  
 Trauma symptoms. 
Many individuals with BPD experience co-occurring post-traumatic stress disorder 
(PTSD). Grant et al. (2008) reported from a large-scale epidemiological survey that 47.2% of 
women with BPD had comorbid PTSD. This is not surprising given that trauma history (e.g., 
sexual abuse, physical abuse) is a strong predictor of self-harm behaviors (see review, Lang & 
Sharma-Patel, 2011) and was proposed to have a causal relationship to BPD (Ball & Links, 
2009).  Comorbid BPD and PTSD significantly increases the rate of suicide attempts, with two to 
five times more likely than BPD or PTSD alone (Pagura et al., 2010). The high prevalence of 
BPD and PTSD prompted the development a prolonged exposure protocol for comorbid BPD 
and PTSD (DBT-PE; Harned et al., 2012), and the findings are promising. 
Research (not specific to DBT) of the role of trauma symptoms is not well understood in 




history of sexual trauma is a moderator of treatment outcome for PTSD (Markowitz, Neria, 
Lovell, Meter, & Petkova, 2017). Markowitz and colleagues (2017) found that interpersonal 
psychotherapy, prolonged exposure, and relaxation therapy were all efficacious in reducing 
PTSD symptoms, individuals with a sexual trauma history responded better to interpersonal 
therapy than prolonged exposure or relaxation therapy. However, another study does not show 
sexual trauma as a moderator of treatment outcome (Diamond, Creed, Gillham, Gallop, & 
Hamilton, 2012). The disparate findings may be accounted for by treatment type and population. 
Markowitz and colleagues (2017) tested Prolonged Exposure (PE; Foa & Rothbaum, 1998), 
Interpersonal Psychotherapy (IPT; Markowitz, 2016), and Progressive Relaxation (PR; Jacobsen, 
1938) for adults with PTSD, while Diamond and colleagues (2012) tested Attachment-based 
Family Therapy (ABFT; Diamond, Reis, Diamond, Siqueland, & Isaacs, 2002) for suicidal 
adolescents with sexual trauma history. These findings highlight the need for further research of 
the effects of pre-existing PTSD-symptoms on treatment outcome.  
The proposed study is important for several reasons. First, it provides researchers and 
clinicians with a better understanding of factors that predict treatment response of DBT. This 
information can guide treatment adaptations that may increase treatment effectiveness for DBT 
clients. Second, this information can guide how an organization (e.g., psychiatric hospital) 
implements DBT. Third, the results can guide future adaptations and iterations of DBT. For 
instance, DBT-skills protocols have been developed for co-occurring BPD and substance use 
disorder (DBT-SUDS; Linehan, 2014), PTSD (DBT-PE; Harned, Korslund, Foa, & Linehan, 





 The aim of the proposed study was to identify treatment predictors of DBT among 
adolescent patients in a residential treatment program. There were five hypotheses of the 
proposed study.  
1. As residents’ level of emotion dysregulation difficulties increased at pre-treatment (DER-
36 scores), they would show less change of BPD symptoms at post-treatment. 
2. As residents’ level of social-anxiety symptoms increased at pre-treatment (BFNE scores), 
they would show less change of BPD symptoms at post-treatment. 
3. As residents’ level of PTSD symptoms increased at pre-treatment (PCL-5 scores), they 
would show less change of BPD symptoms at post-treatment. 
4. As residents’ level of intolerance of uncertainty increased at pre-treatment (IUSC scores), 
they would show less change of BPD symptoms at post-treatment. 
5. As residents’ level of experiential avoidance increased at pre-treatment (AAQ-II), they 
would show less change of BPD symptoms at post-treatment. 
Method 
Data Collection Procedures 
Adolescent females (N = 107) aged 13 to 18 (mean age = 15.88, SD = .96) who were 
admitted to a residential program with significant emotion dysregulation and/or self-harm 
urges/actions and suicidal ideation. During the admission process, residents provided informed 
assent and their parents provide informed consent to allow data to be used for research purposes. 
Residents and their parents completed a battery of questionnaires that included demographic 
information, medical history, and clinical measures. All clinical measures administered at pre-
treatment were administered again at post-treatment. The current study was approved by the 




Adolescent DBT program 
To ensure the fidelity of DBT, the psychiatric hospital employed a DBT consultant who 
was certified by Behavioral Tech (a Linehan-founded organization) to aid in program 
development and implementation. 
DBT-skills training for residents. 
Clients in the residential program received group-based DBT-A skills training five days 
per week, with a different module taught each day: Mondays = Core Mindfulness; Tuesdays = 
Distress Tolerance; Wednesdays = Emotion Regulation; Thursdays = Interpersonal 
Effectiveness, and Fridays = Middle Path. The schedule was developed to ensure that all skills 
are taught at least twice prior to discharge. Clients also received weekly individual therapy, 
medication management, and adjunctive activities (e.g., art therapy, experiential therapy, 
outings). DBT skill use was reinforced by the milieu.  
DBT-A includes five core modules: Mindfulness, Distress Tolerance, Emotion 
Regulation, Interpersonal Effectiveness, and Walking the Middle Path. Mindfulness skills teach 
clients to consciously bring awareness to the present moment without judgment. For instance, 
clients are taught how to bring awareness to the breath and how to non-judgmentally observe 
thoughts and behaviors. Distress Tolerance skills provide clients with ways to cope in the short-
term that are more effective than engaging in self-harm behaviors. The primary goal of Distress 
Tolerance skills is help manage difficult situations without making them worse. Emotion 
Regulation skills provide clients with an in-depth understanding of emotions and their associated 
responses. Clients learn how to mitigate and/or prevent negative emotions with these skills. 
Interpersonal Effectiveness skills help clients achieve interpersonal goals including effectively 




the Middle Path skills help parents and adolescents to better understand each other’s perspective, 
which can deescalate volatile situations and promote effective resolution. Validation strategies 
are emphasized in this module. Skills-based phone coaching, therapist consultation team, and 
phone coaching are included with comprehensive DBT-A. Skill use and generalization is an 
important aspect of DBT. It was shown to fully mediate the likelihood of suicide attempts, 
depression, and anger control, and partially mediated the likelihood of non-suicidal self-injury 
(Neacsiu, Eberle, Kramer, Wiesmann, & Linehan, 2014). 
Measures 
 Treatment predictors.  
Emotional dysregulation. 
The Difficulties in Emotion Regulation Scale (DERS-36; Gratz & Roemer, 2004) is a 36-
item self-report measure that assesses emotion regulation across six factors (Goals, Clarity, 
Strategies, Impulse, Awareness, and Nonacceptance). The DERS-36 was designed to measure a 
broad range of relevant difficulties of emotion regulation as described by several theories of 
emotion regulation. Factor analysis supported a six-factor structure of the measure. Factor 1 
(Nonacceptance) reflects a tendency to reject/not accept one’s own emotional distress. Factor 2 
(Goals) is characterized by inhibited goal attainment when experiencing negative emotions. 
Factor 3 (Impulse) indicated difficulties inhibiting maladaptive action urges when emotionally 
distressed. Factor 4 (Awareness) reflects a lack of attention or awareness of emotional responses. 
Factor 5 (Strategies) represents one’s belief that little can be done to regulate difficult emotions. 
Factor 6 (Clarity) taps into the extent to which an individual can accurately identify experienced 
emotions. The DERS Total score has demonstrated high internal consistency (α = .93), construct 




for the use of the DERS with adolescent populations (Neumann, van Lier, Gratz, & Koot, 2010; 
Perez, Venta, Garnaat, & Sharp, 2012; Weinberg & Klonsky, 2009). The DERS contains items 
that are rated on a 5-point Likert-type scale: 1 (almost never), 2 (sometimes), 3 (about half the 
time), 4 (most of the time), and 5 (almost always). Several items are reversed scored. The total 
score range is from 36 to 180 with higher scores indicative of greater emotion regulation 
difficulties. Internal consistency within the current sample was high (α = .87). 
Social anxiety symptoms. 
The Brief Fear of Negative Evaluation Scale (BFNE; Leary, 1983) is 13-tiem self-report 
measure that assesses one’s tolerance of the possibility they will be judged negatively in social 
situations. The BFNE assesses the degree to which an individual experiences apprehension 
toward the prospect of being evaluated negatively. Items are rated on a 5-point scale: 1 (not at all 
characteristic of me), 2 (slightly characteristic of me), 3 (moderately characteristic of me), 4 
(very characteristic of me), and 5 (extremely characteristic of me). Total scores range from 13 to 
65, with higher scores indicating a greater degree of fear of negative evaluation than lower 
scores. The BFNE has shown excellent internal consistency (α = .90) and high test-retest 
reliability (r = .68) after four weeks (Leary, 1983). Internal consistency within the current sample 
was acceptable (α = .65). 
 Trauma symptoms.  
The PTSD Checklist for DSM-5 (PCL-5; Blevins, Weathers, Davis, Witte, & Domino, 
2015) is a 20-item self-report measure that assess key features of PTSD. The PCL probes PTSD 
symptoms experienced within the past month on a scale from 1 (not at all) to 5 (extremely). Total 
scores range from 17 to 85, and cut-off scores are interpretations are provided: 17-29 (little to no 




sample, the PCL-C total score demonstrated excellent internal consistency (α = .94), high test-
retest correlations coefficients after one-week (r = .92) and two-weeks (r = .68), and evidence of 
convergent validity (Ruggiero, Del Ben, Scotti, & Rabalais, 2003). Internal consistency within 
the current sample was excellent (α = .94). 
Intolerance of uncertainty.  
The Intolerance of Uncertainty Scale for Children (IUSC; Comer et al., 2009) is a 27-
item measure that assess children’s (aged 7 to 17) level of negative reactivity to ambiguous 
situations. The IUSC was adapted from the adult version of the intolerance of uncertainty scale 
(Buhr & Dugas, 2002). Respondents rate each item on a 5-point Likert-type scale which three 
anchor points: 1 (not at all), 3 (somewhat), and 5 (very much). Total scores range from 27 to 135. 
The IUSC has demonstrated strong internal consistency (α = .92) and convergent validity 
(Comer et al., 2009). Internal consistency within the current sample was excellent (α = .94). 
Experiential avoidance. 
The Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 2011) is a 7-item self-
report measure that assesses experiential avoidance and cognitive inflexibility. The AAQ-II was 
adapted from the original Acceptance and Action Questionnaire (AAQ; Hayes et al., 2004). Each 
item is rated on a 7-point scale from 1 (never true) to 7 (always true). Items 1, 6, and 10 are 
reverse scored. The total score range is from 7 to 49, and lower scores indicate greater levels of 
experiential avoidance. The AAQ-II has shown strong psychometric properties across six 
independent samples. The mean internal consistency across samples was good (α = .84), test-
retest reliability after 3-months and 12-months was high (r = .81 and r = .79, respectively), and 
convergent and incremental validity was supported. Internal consistency within the current 




 Primary outcome measure. 
 DBT aims to reduce borderline symptoms. Thus, the primary outcome measure for the 
current study is the Borderline Symptom List (Bohus et al., 2009), a validated measure that is 
listed as an assessment instrument for use in DBT research by the Linehan Institute.  
The Borderline Symptom List short-version (BSL-23; Bohus et al., 2009) is a briefer 
version of the original BSL with 95 items (Bohus et al., 2007). The BSL-95 was developed to 
assess symptoms of BPD according to DSM-IV-TR criteria. Clinical experts and clients with 
BPD were also interviewed. The BSL-23 was developed to provide a valid measure of BPD 
symptoms with less respondent burden than the BSL-95. The items selected for the BSL-23 
showed the greatest sensitivity to change and the largest discriminant validity when identifying 
individual with and without BPD. Across multiple samples, the BSL-23 showed large 
correlations with the BSL-95, rs > .95), excellent internal consistency (α = .93), and a strong 
discriminant validity (mean effect size = 1.13). Internal consistency within the current sample 
was excellent (α = .90). 
Secondary outcome measures.  
Secondary outcome measures were selected to assess improvements in other important 
areas of life, including depressive symptoms and quality and satisfaction with life.  
The Quick Inventory of Depressive Symptomatology (QIDS-SR; Rush et al., 2003). 
The QIDS-SR is a 16-item self-report measure that was developed to assess DSM-IV 
symptom criterion domains of depression (e.g., mood, sleep, suicidal ideation). The QIDS-SR 
has high internal consistency (α = .86), high convergent and concurrent validity, and is sensitive 
to change. Items are rated on a 0 to 3 scale, with no standardized anchor points. Not all item 




27. High scores represent greater severity than lower scores. Internal consistency within the 
current sample was excellent (α = .99). 
 The Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q; 
Endicott, Nee, Yang, & Wohlberg, 2006). 
 The PQ-LES-Q is a 15-item self-report measure that assesses a broad range of life aspects  
relevant to children and adolescents. Across three independent samples, the PQ-LES-Q  
demonstrated good internal consistency (alphas ranged = .87 to .90) and test-retest reliability  
(screening to baseline = .78). Items are rated from 1 to 5 (“very poor,” “poor,” “fair,” “good,”  
and “very good,” respectively). The first 14 items are summed to form a total score ranging from 
14 to 70, with higher scores representing greater enjoyment and satisfaction.  Internal 
consistency within the current sample was excellent (α = .99). 
Data Analytic Plan 
Methodological Consideration for Primary Outcome Indices: Residual change 
scores. 
 Linear regression analyses were conducted to test the study hypotheses. There is, 
however, discussion about how to best assess outcome in the literature. It is common for 
researchers to employ simple change (gain) scores to assess intervention effects. Simple change 
scores are calculated by subtracting Time 2 scores from Time 1 scores (e.g., depression before 
intervention was 60, after intervention it was 20; thus, there was a decrease of 40 points in 
depression). This method of assessing treatment effects has drawn controversy in the literature 
with some advocating that they can be useful under certain conditions (Castro-Schilo & Grimm, 
2018; Gottman & Rusche, 1993; Rogosa & Willett, 1983; Williams, & Zimmerman (1996), 




Cronbach and Furby (1970) highlighted a common concern with simple changes scores, that 
subtracting pretest scores from posttest scores leads to erroneous conclusions due to random 
error of the measurement. For instance, obtaining “observed” data at two time points results in an 
amalgam of measurement error that may indicate “true” change when in fact it is not. Rather, 
inferred “true” change may merely represent the measurement error at two time points. Another 
issue with simple change scores is regression to the mean (Barnett, van der Pols, & Dobson, 
2005). That is, observing atypically high/low scores during one observation will be observed less 
during subsequent observations as scores trend toward the “true” score (i.e., mean score). This is 
problem is highlighted by Adams, Houle, Parker, and Burkee (2012) who examined changes to 
depressive symptoms during substance abuse treatment. They found that participants showed 
significant improvements in symptoms reductions; however, further analyses indicated 
regression to the mean accounted for some of the observed change.  
Residual change scores were computed in SPSS by conducting a simple linear regression 
with post-treatment outcome scores (e.g., BSL-23) regressed onto pre-treatment outcomes scores 
with ‘standardized’ residuals saved. Data points that fall below the regression slope produce 
negative residual change scores, which indicate that a resident showed more symptom reductions 
at post-treatment than would be expected after controlling for pre-treatment scores (see Figure 
1). Values that fall above the regression line produce positive residual change scores, which 
indicate that there were less symptom reductions than would be expected after controlling for 
pre-treatment scores. Therefore, residual change scores can index the magnitude of symptom 
change while taking into consideration the baseline level of symptom severity. The primary 
outcome measure was residual change scores of the BSL-23. Secondary outcome indices were 




Reliable change, reliable change index, and clinically significant change. 
Assessing symptom changes from pre-treatment to post-treatment is essential to clinical 
research. Yet, many studies rely on examining between-group symptom changes, and this group-
level of analysis does not allow researchers to draw conclusions about individual changes. 
Barlow and Nock (2009) proposed that an individual is the primary unit of analysis in the 
psychological sciences.  
This goal of assessing ideographic phenomena can be partially achieved with a statistical 
approach developed by Jacobson and Truax (1991) called reliable change (RC) and the reliable 
change index (RCI). RC represents the amount of change (or difference between pre-treatment 
and post-treatment) in SD units rather than simple change scores. Unless there is equal change 
among individuals, each individual will have a different RC score. Given the use of SD units to 
assess change, an RC greater than 1.96 (2 SDs) indicates a statistically reliable change (beyond 
what would be expected from measurement error alone). RCI represents the absolute value of the 
difference score (which is computed based on the reliability and variability information of the 
particular measure) needed to determine whether observed changes were statistically reliable and 
not a function of measurement error.   
Once it is established that observed changes are statistically reliable, the next step is to 
assess whether the changes are clinically meaningful. That is, has clinically significant change 
(CSC) occurred to extent than an individual moved from an affected group (BPD) to an 
unaffected group (Normal Control)? CSC can also be used to assess whether an individual 
deteriorated during an intervention. Jacobson, Follette, and Revenstorf (1984) provided the 
following definition of clinical significance: “a change in therapy is clinically significant when 




(p.340). This definition of clinical significance is predicated on the assumption that the “normal” 
or “functional” range of the population is known. Normative data were available from the 
psychometric study of the original BSL with 95 items (Bohus et al., 2007).  
To calculate the RC, RCI and CSC, there are several pieces of information that are 
needed including, pre- and post-treatment scores, SD of measure, reliability of the measure 
(preferably test-retest or internal consistency), and a cutoff score or reported means of affected 
and unaffected samples of the outcome measure to establish a CSC threshold.  
Procedures for establishing reliable change and reliable change index. 
1. Calculate standard error of measurement (SEM = s√1-rxx)  
a. s = SD of reference group 
b. rxx = reliability of the instrument (test-retest or Chronbach’s alpha) 
2. Calculate SDiff = √2(SEM2) 
a. SDiff = SD of the errors of measurement of the difference scores  
3. Calculate the difference score for each individual  
a. Diff = MeanT1 – MeanT2   
4. RC = (MeanT1 – MeanT2)/SDiff 
a. RC > 1.96 = reliable change (an individual’s standardized score) 
5. RCI = (1.96)*SDiff 
a. The RCI for the BSL-23 was (1.96)*(.46) = .89 for the current study. Thus, any 
resident with a difference score greater than the absolute threshold of .89 was 
considered to show statistically reliable change. 




A cutoff score was calculated according to recommendations of Jacobson and Truax 
(1991) who proposed three different methods for calculating a cutoff point (methods: a, b, and c) 
that indicates a resident moved from the “dysfunctional” distribution to the “normal” 
distribution.  
Cutoff score method ‘a’ is recommended when data from a “normal” distribution is 
unknown. Cutoff score ‘a’ is calculated by using the “dysfunctional” distribution mean and 
moving two SDs in the direction of the “normal” distribution (i.e., symptom reductions). 
Jacobson and Truax (1991) posited that cutoff score ‘a’ will be too conservative when the 
distributions overlap, as is the case of the psychometric data provided by Bohus and colleagues 
(2007) that showed that individuals with BPD (n = 308) had a BSL-95 mean score of 2.0 (SD = 
.76) and healthy controls (n = 204) had a BSL-95 mean score of 0.4 (SD = .22). Cutoff score ‘b’ 
represents the mean of the “normal” distribution plus 2*SD of the pre-treatment scores. Cutoff 
score ‘b’ is relatively lenient relative to ‘a’ and ‘c’ and equaled .84 in the current study. Cutoff 
score ‘c’ represents the mid-point between the “dysfunctional” and “normal” distributions. Using 
the Jacobson and Truax (1991) formula to calculate cutoff score ‘c,’ mean BSL-23 score at post-
treatment equaled .77 in the current study. This was problematic, given that the mean of the 
“dysfunctional” distribution was 2.0 and SD was .76 (Bohus et al., 2007). Thus, using cutoff 
score ‘c’ according to Jacobson and Truax would be too lenient in the current sample, with the 
CSC threshold approximately half of a SD away rather than the two SD recommendations.  
Given that cutoff scores computed with ‘b’ and ‘c’ did not make theoretical sense given 
the obtained cutoff scores, method ‘a’ was employed, which is justified considering that the 
obtained CSC cutoff score of the current study was .48, which is closer to the “normal” 




(.77). Cutoff score ‘a’ was the most conservative of the three and selected to protect against Type 
I error. Residents who met the RC and RCI threshold were classified as CSC if their mean BSL-
23 score was .48 or lower at post-treatment; Resident were classified as no CSC if they met the 
RC and RCI threshold but not the cutoff score. Finally, residents were classified as deteriorated 
if they met the RC and RCI threshold in the opposite direction (i.e., increased borderline 
symptoms). See Figure 2 for illustration. 
Results 
Study Hypotheses 
Do emotion dysregulation symptoms at pre-treatment predict symptom change on BSL-
23?  
Simple-linear regressions were conducted to test the hypotheses that residents with 
greater DERS-36 scores at pre-treatment would show less reductions of borderline symptoms, 
depressive symptoms, and poorer quality of life than residents with lower DERS-36 scores at 
pre-treatment. The hypotheses were not supported, see Table 2. Pre-treatment DERS-36 scores 
did not predict residual change of BSL-23scores, F(1, 89) = .01, b = .01, t = .09, p = .93. 
Additionally, DERS-36 scores did not predict QIDS, F(1, 89) = .72, b = -.09, t = -.85, R2 <.01, p 
= .40, or PQ-LES-Q, F(1, 89) = 1.19, b = .12, t = 1.09, R2 = .01, p = .28, residual change scores.  
Do social anxiety symptoms at pre-treatment predict symptom change on BSL-23? 
Due to the low sample size of the BFNE responses (n = 10), there was not enough 
statistical power to detect a significant effect. Nevertheless, the analyses were conducted to 
provide preliminary data on the association between pre-treatment BFNE scores and outcome by 
examing effect sizes (i.e., R2). Three separate simple-linear regressions were conducted to test 




reductions of borderline symptoms, depressive symptoms, and poorer quality of life. The 
hypotheses were not supported, see Table 2. Pre-treatment BFNE scores did not predict residual 
change of BSL-23 scores, F(1, 9) = .01, b = .01, t = -.02 p = .95, R2 < .01. Additionally, BFNE 
scores did not predict QIDS, F(1, 9) = .20, b = .15, t = -.85, R2 = .02, p = .66, or PQ-LES-Q, F(1, 
19) = .13, b = .08, t = .36, R2 < .01, p = .72, residual change scores. Only 2% of the variance in 
residual change of BSL-23 was account for by pre-treatment BFNE scores, and less than 1% 
variance was accounted in residual change of QIDS and PQ-LES-Q. 
Do PTSD symptoms at pre-treatment predict symptom change on BSL-23?  
Three separate simple-linear regressions were conducted to test the hypotheses that 
residents with increased PCL-5 scores at pre-treatment would show less reductions of borderline 
symptoms, depressive symptoms, and poorer quality of life than residents with lower PCL-5 
scores at pre-treatment. The hypotheses were not supported, see Table 2. Pre-treatment PCL-5 
scores did not predict residual change of BSL-23 scores, F(1,19) = .05, b = .05, t = .23, R2 < .01, 
p = .82. Additionally, PCL-5 scores did not predict QIDS, F(1, 19) = .01, b = .02, t = .08, R2 < 
.01, p = .94, or PQ-LES-Q, F(1, 19) = .13, b = .08, t = .36, R2 < .01, p = .72, residual change 
scores. 
 Does level of intolerance of uncertainty at pre-treatment predict symptom change on 
BSL-23?  
Three separate simple-linear regressions were conducted to test the hypotheses that 
residents with increased IUSC scores at pre-treatment would show less reductions of borderline 
symptoms, depressive symptoms, and poorer quality of life than residents with lower IUSC 
scores at pre-treatment. The hypotheses were not supported, see Table 2. Pre-treatment IUSC 




p = .09. Additionally, IUSC scores did not predict QIDS, F(1, 89) = .97, b = .12, t = 1.16, R2 
=.02, p = .25, or PQ-LES-Q, F(1, 89) = 1.88, b = -.14, t = -.14, R2 = .02, p = .17, residual change 
scores. 
Does Level of Experiential Avoidance at Pre-treatment Predict Symptom Change on 
BSL-23?  
Due to the low sample size of the AAQ-II responses (n = 6), there was not enough 
statistical power to detect a significant effect. Nevertheless, the analyses were conducted to 
provide preliminary data on the association of AAQ-II and outcome by examing effect sizes (i.e., 
R2). Three separate simple-linear regressions were conducted to test the hypotheses that residents 
with increased AAQ-II scores at pre-treatment would show less reductions of borderline 
symptoms, depressive symptoms, and poorer quality of life.. Three separate simple-linear 
regressions were conducted to test the hypotheses that residents with increased AAQ-II scores at 
pre-treatment would show less reductions of borderline symptoms, depressive symptoms, and 
poorer quality of life.. The hypotheses were not supported, see Table 2. Pre-treatment AAQ-II 
scores did not predict residual change of AAQ-II scores, F(1, 5) = 2.89, b = .61, t = 1.70, R2 = 
37, p = .15.  Additionally, AAQ-II scores did not predict QIDS, F(1, 5) = 1.37, b = .46, t = 1.17, 
R2 = .22 p = .30, or PQ-LES-Q, F(1, 5) = 2.28, b = .56, t = -1.51, R2 = .31, p = .19, residual 
change scores. Power for the current regression was not sufficient; however, the effects sizes 
were small to medium, and the slopes suggest that as AAQ-II scores increase at pre-treatment, 
residents were more likely to show more BSL-23 reductions than expected. This trend is in the 
direction of the study hypothesis. 
Secondary Data Analyses 




 An RC score was computed for each resident on the BSL-23 (see Data Analytic Plan). 
Resident were classified as (RC = 1, No RC = 0).  Results of the classification revealed that 51 of 
92 (55%) of the residents showed reliable change on the BSL-23 from pre- to post-treatment. 
Next, the RCI was computed (RCI absolute threshold = .89) to determine the direction of the 
reliable change by classification (RC = 1, No RC = 0, Deteriorated = -1). Results of the 
classification revealed that 51 of 92 (55%) of the residents showed RC, 38 of 92 (41%) showed 
no RC, and 3 of 92 (3%) showed RC toward deterioration. Finally, CSC classification was done 
by assessing residents who met the RC/RCI threshold and whose BSL-23 post-treatment score 
was below the cutoff score (mean = .44). Of the 51 residents who met the RCI threshold, 22 were 
considered CSC, meaning that 27% showed enough improvement on the BSL-23 that they would 
likely fall within the “normal” distribution. Sixty-seven of the residents (73%) showed RCI but 
not CSC, and 3 of the 92 residents (3%) showed CSC toward deterioration. Table 3 provides RC, 
RCI, and CSC status for each of the residents in the analysis. 
Do pre-treatment clinical symptom scores predict clinically significant change? 
Binary logistic regressions were conducted to test the extent to which pre-treatment 
clinical scores (e.g., DERS-36, AAQ-II) predicted a resident’s group classification at post-
treatment: 1 = clinically significant change (CSC) or 0 = no clinically significant change (No 
CSC; see Table 4). Those who deteriorated were classified as No CSC for purposes of the 
analyses. 
The DERS-36 Total score at pre-treatment was not a significant predictor of group 
classification, B = .01, SE = .01, Wald = 1.33, p = .25, Exp(B) = 1.01, Cox & Snell R2 = .02. For 
every one-unit increase in DERS-36 Total score at pre-treatment, there was a 1.01 increased 




factor subscales of the DERS-36 at pre-treatment revealed that they were not significant 
predictors of group classification (ps ranged = .11 to .99). Awareness was approaching 
significance, p = .11, Exp(B) = 1.11, trending in the direction of a 1.11 increased chance of being 
classified as CSC for every one-unit increase in Awareness at pre-treatment.  
 Social anxiety symptoms at pre-treatment did not predict group classification, B = .03, SE 
= .13, Wald = .05, p = .83, Exp(B) = 1.03, Cox & Snell R2 = <.01. However, the analysis was 
underpowered (n = 7). The data trend reflected a 1.03 increase chance of being classified in the 
CSC group for every one-unit increase in BFNE score at pre-treatment.  
 Trauma symptoms at pre-treatment did not predict group classification, B = .02, SE = .13, 
Wald = .65, p = .42, Exp(B) = 1.02, Cox & Snell R2 = .03. This analysis was also underpowered 
(n = 8). The data trend reflected a 1.02 increase chance of being classified in the CSC group for 
every one-unit increase in PCL-5 pre-treatment score. 
Experiential avoidance symptoms at pre-treatment did not predict group classification, B 
= -0.13, SE = .12, Wald = 1.10, p = .29, Exp(B) = .88, Cox & Snell R2 = .18. The analysis was 
underpowered (n = 4); however, the results trended in the opposite direction of the study 
hypothesis. For every one-unit increase in AAQ-II score at pre-treatment, there was a 1.12 
decreased chance of being classified as CSC.  
Intolerance of uncertainty was not a significant predictor of group classification, B = -.01, 
SE = .01, Wald = .19, p = .66, Exp(B) = 1.00, Cox & Snell R2 <.01. See Table 5 for a summary of 
the results. 
Discussion 
 While DBT is an effective treatment for adults and adolescents with BPD and BPD-like 




opportunities for researchers to identify ways to increase treatment response. This line of 
research can help improve outcome for individuals receiving DBT, reduce the amount of 
resources needed to provide the treatment (e.g., shorter intervention duration), and inform ways 
to adapt future DBT protocol iterations. 
Thus, the aim of the current study was to test the extent to which pre-treatment factors 
predicted response to DBT among adolescent females in residential care. We predicted that as 
residents’ clinical symptom scores increased at pre-treatment, they would show less symptom 
reductions than residents with decreased baseline clinical symptoms. Independent linear 
regression analyses did not support the study hypotheses. While there were symptom 
improvements across most measures from pre-treatment to post-treatment, no predictive 
variables accounted for a significant amount of variance in residual change scores of the BSL-23, 
QIDS, or PQ-LES-Q.  
 Neither difficulty in emotion regulation or intolerance of uncertainty scores at pre-
treatment were significant predictors of residual change of outcome. While the ability to 
regulation one’s emotions is a proposed mechanism of change in BPD symptom (Gratz et al., 
2012), the current results suggest that emotion regulation difficulties at pre-treatment do not 
interfere with treatment response. Intolerance of uncertainty has not been studied within the 
context of BPD and treatment response. McEvoy and Mahoney (2012) posited that intolerance of 
uncertainty is a mechanism of change across several psychiatric disorders, particularly those 
associated with negative affect. The current study was first to assess the relationship between 
pre-treatment intolerance of uncertainty severity and treatment outcome. The study hypothesis 
was not supported, pre-treatment intolerance of uncertainty did not predict residual change of 




that uncertainty levels decrease quickly; thus, limiting the extent to which it affects treatment 
response.   
There was an inadequate sample size to analyze three of the study predictor measures 
(i.e., AAQ-II, BFNE, and PCL-5); thus, interpretations of these results should be taken with 
caution and serve to provide preliminary data and trends. The results indicated that level of pre-
treatment experiential avoidance was not a significant predictor of residual outcome in the 
current study, which is counter to the results of Perroud and colleagues (2010) and Rüsch and 
colleagues (2008) who found that individuals with higher levels of pre-treatment experiential 
avoidance were associated with higher levels of premature dropout than individuals with lower 
levels of pre-treatment experience avoidance. Of note, Perroud and colleagues (2010) assessed 
response from an outpatient sample, and both Perroud and colleagues and Rüsch and colleagues 
(2008) assessed treatment dropout rather than symptom reductions. Social anxiety symptoms 
were also not a significant treatment predictor, which is inconsistent with the findings of Dimeff 
and colleagues (2000) who that social anxiety interfered with response to DBT among 
individuals with comorbid BPD and substance use disorder. There are two important distinctions 
between the study by Dimmeff and colleagues (2010) and the current study. First, the current 
study was conducted in a residential setting where residents cohabitate with each other 24-hour 
per day rather than an outpatient setting (Dimeff et al., 2010) where contact between individuals 
is generally once per week for two to three hours per interaction. Second, substance use disorder 
was not a treatment target of the current study and, in fact, was a rule out for admission. 
Together, these differences in social contexts and profile of psychiatric comorbidity may have 
contributed to the divergent findings between the studies. Pre-treatment trauma symptoms did 




symptoms from pre-treatment to post-treatment; however, trauma symptoms were not a target of 
DBT among this resident population who were considered Stage 1 DBT clients (i.e., those with 
active self-harm urges/action and suicidal ideation). Again, the analysis was underpowered. 
Preliminary results suggest that core DBT skills may reduce PTSD symptoms, even when not a 
target of treatment however, the mechanism of change remains unclear.  
Secondary analyses assessing individual-level analyses (i.e., RC, RCI, CSC) showed that 
23% of the current sample showed CSC, 72% showed no CSC, and 3% deteriorated. While these 
values are lower than the response rates of reported by Kröger and colleagues (2013; CSC = 
45%, no CSC = 30.6%, deterioration = 11%, premature dropout = 10%), these authors calculated 
a CSC threshold of .80 which is more liberal than the .40 CSC threshold of the current study. 
Additionally, Kröger and colleagues (2013) sample was older (mean age = 32.0, SD =10.27) 
than the mean age of the current sample (mean age = 15.88, SD = .96).  
Overall, the results trended in the direction that higher clinical symptom scores at pre-
treatment were predictive of greater residual change on outcome. While these trends are counter 
to the current hypotheses, they suggest that DBT in residential settings is robust against pre-
treatment clinical symptoms and is effective for treating those with a range of pre-treatment 
clinical severity. Further, the disparate findings can also be attributed to methodological 
differences, particularly the way in which outcome was assessed among most treatment-outcome 
studies (simple change scores) compared to the current study (residual change scores). Simple 
change scores are affected by ceiling and floor effects (i.e., regression to the mean). 
A possible explanation for the non-significant effects of pre-treatment clinical symptoms 
on outcome can be attributed to the ‘high dose’ of DBT that residents receive. For instance, each 




received individual therapy sessions, family sessions (to intervene in the environment), and 
DBT-skills generalization group. Line therapists (residential counselors and behavior specialists) 
were also trained in DBT and reinforced effective skill use, while blocking or redirecting 
residents who were dysregulated and not effectively using skills. The ‘high dose’ of DBT 
received in a residential setting is vastly different than outpatient settings where adolescents 
attend a 2-hour skills group and a 1-hour individual session per week. Another possible 
explanation is that DBT is a comprehensive treatment that effectively addresses multiple clinical 
features characterized by emotion dysregulation difficulties (e.g., social anxiety, experiential 
avoidance). Indeed, recent research suggests that DBT skills can be applied for transdiagnostic 
emotion dysregulation difficulties (Neacsiu et al., 2014; Ritschel, 2015). Therefore, an individual’s 
clinical presentation at pre-treatment may not be as important in residential settings as it may be 
in other treatment settings.  
Importantly, the CSC rate of the current study (22%) was low. While Kröger and 
colleagues (2013) found a CSC rate of 45% among an inpatient sample, as mentioned before, 
their cutoff score (.8) was more liberal than the cutoff score (.4) of the current study. 
Additionally, their sample included adults rather than adolescents. Further, it has been noted that 
residential programs are not designed specifically to reduce symptoms to a level of remission. 
Instead, residential programs are tasked with the goal of reducing acute harm and providing an 
environment for stabilization to occur (Whittaker et al., 2016). After discharge, residents often 
take a step-down approach in treatment, with some residents continuing with partial 
hospitalization program (PHP), intensive outpatient program (IOP), or general outpatient 





There were several limitations to the current study. First, there were barriers to the feasibility 
of conducting a treatment outcome study within a large medical setting; thus, a feasibility 
analysis is provided below. Second, the current study was not a randomized controlled trial, so 
there was no comparison group to assess similarities and difference between the current sample. 
So, although the aim of current study was to assess treatment predictors, inferences of treatment 
efficacy are limited. Additionally, comparison of CSC rates at post-treatment without a similarly 
representative pre-treatment control group limit interpretation. Third, the sample consisted of 
female adolescents in a residential setting; thus, the generalizability of the results to other 
populations is limited. Fourth, obtaining data at multiple time points throughout treatment (e.g., 
weekly) would provide a greater understanding of the idiographic patterns of treatment response. 
For instance, if a resident showed elevated intolerance of uncertainty at pre-treatment, weekly 
assessment would help to flesh out how these symptoms progress (increase, decrease, remain 
unchanged) during the course of treatment. Finally, the exploratory nature of this study and large 
number of analyses relative to sample size increases the likelihood of Type I error; thus, the 
findings are preliminary and in need of further investigation.  
Feasibility Analysis. 
The primary purpose of a feasibility analysis is to ensure that an objective (e.g., research, 
treatment implementation) can be done effectively. Bowen and colleagues (2009) posited eight 
areas to focus on when considering feasibility research. Three areas (Implementation, 
Practicality, and Integration) are particularly relevant for barriers experienced in the current 
study. Implementation is the area that focuses on the extent to which an objective can be 




resources are constrained in some way. Integration addresses the level of system change needed 
to integrate a new objective.  
In the current study, there were several barriers to data collection including changes to the 
planned data collection procedures, implementation of formal IRB procedures, and lower rates of 
assent/consent for study enrollment than expected. The current study was conducted in a large 
psychiatric hospital system whose primary aim is to deliver high-quality clinical services. As 
such, there were limited research resources (Practicality) and IRB protocols (Implementation). 
Recently, the organization increased its focus to collect clinical data for research purposes 
(Integration), but with some systematic challenges.  
The hospital has seen a rapid expansion, locally and nationally. This growth strains existing 
resources, including the availability of those who maintain and process data. Further, there were 
procedural changes to obtaining the de-identified data from the organization, which made it 
difficult to obtain data for analyses. It is unclear how procedural changes were communicated 
(e.g., electronic communication, scheduled trainings) to units within the organization. 
Recommendations for Future Research in Community Settings.  
Pilot studies. 
Prior to data collection, a pilot study should be conducted to evaluate whether data collection 
procedures were implemented as intended. McHugh and Barlow (2010) defined implementation 
as “the process of transferring the treatment to the clinical setting (e.g., training).” A pilot study 
will increase the likelihood that an intervention or objective (e.g., data collection) can be 
administered and completed with high fidelity, which in turn will protect against threats to 
internal validity. A pilot study will also ensure that implementing new protocols can be 




pilot study is often short-term; thus, if there are challenges integrating an objective, changes can 
be made or terminated with minimal impact to the organization. 
In retrospect, if the current study was pilot tested, the research investigators would have been 
involved, or have communication with, relevant departments who administer the organizational 
protocols such as screening, recruitment, retention, treatment adherence, treatment fidelity, and 
assessment (Leon, Davis, & Kraemer, 2011).  
Effective collaboration with IRBs across multiple organizations. 
The IRB is tasked with ensuring that research of animals and humans is conducted ethically, 
with minimal harm, and with benefit to populations being examined (Schneider, 2013). While 
precedent has been set for IRB guidelines and standards, there remains variability across 
organizations in IRB procedures (Shore et al., 2011). Given these differences in IRB procedures, 
it is important for researchers to remain in regular contact with involved IRBs across 
organizations. In the current study, IRB procedures and which organization to defer to was 
unclear. Further complicating IRB approval were changes to the IRB procedures among one of 
the organizations that implemented a formal IRB procedure after data collection for the current 
study began. Thus, regular communication between the study investigators and organization’s 
IRB may have decreased the barriers to data collection. Additionally, it would ensure that 
involved organizations and research investigators have a shared definition and clear guidelines 
for executing a study. It was unclear how the organization that implemented a formal IRB during 
active data collection communicated changes to relevant parties.  





In the current study, data was collected and shared between different organizations. This was 
challenging given that access to data for analyses was delayed (sometimes up to several weeks). 
Additionally, different organizations had different infrastructure (e.g., software), and different 
procedures for collecting, deidentifying, and storing data. Therefore, research investigators 
should have a procedure (e.g., monthly communication) with each department involved in the 
study protocol to ensure that data is being collected as intended and accessible when needed. 
This will ensure that any unknown/uncommunicated changes in protocols can be identified prior 
to the completion of data collection.  
Assent and consent. 
Clinical data in real-world settings is needed to affirm that interventions developed under 
tightly controlled conditions translate into real-world results. This can be challenging when 
conducting research with vulnerable populations, including minors under the age of 18. 
Researchers have an ethically duty to ensure that minors and their parents understand the scope 
of the study and their rights as participates to make an informed decision.  
Obtaining assent of child/adolescent to participate in research, in addition to their 
parent/guardian, poses challenges given their vulnerable status. Vitielllo (2003) described assent 
as a clear agreement to participate, rather than the absence of objection. Among individuals 
admitted into the residential program of the current study, approximately 75% of the 
residents/families assented/consented to use data for research purposes. It is unclear whether this 
was a function of refusal or lack of obtaining written documentation.  
Improving assent/consent procedures may increase enrollment rates. Dockett, Perry and 
Kearney (2011) developed assent and information forms for minors, with the aim of promoting 




asked to make decisions about their own participation in research, and they found information on 
the forms helpful. Many of these forms have been developed from research that sought advice 
from minors in the development of information packages (Connors & Stalker, 2007; Jones, 
2004). Institutions may benefit from an increase in enrollment of research when using innovative 
approaches to obtaining assent/consent. Thus, an organization should adopt the spirit of 
evidence-based assessment and treatment so that they can design their measures in a way that 
contributes to research mission. 
Conclusions 
 The current study was the first to examine the extent to which pre-treatment clinical 
symptoms predicted borderline symptom residual change among adolescent females receiving 
DBT in a residential setting. Despite the relatively low sample size, which suggests results 
should be interpreted with caution and more research needed, the results of the current study 
provided preliminary evidence that further supports the use of DBT to treat adolescents with 
emotional dysregulation and BPD-like symptoms within a higher level of care. On average, 
residents showed reductions of symptoms across clinical measures from pre- to post-treatment. 
Further, most residents (55%) showed RC in the direction of improvement and 24% showed 
CSC. Importantly, the findings from the current study suggest that DBT delivered in a residential 
setting is robust against pre-treatment symptom severity as pre-treatment clinical scores across 





Adams, C. E., Houle, T. T., Parker, J. D., & Burke, R. S. (2012). Examining changes in  
depressive symptoms during substance abuse treatment in the context of regression to the 
mean. Addictive Disorders & Their Treatment, 11(4), 183-194. 
Axelrod, S. R., Perepletchikova, F., Holtzman, K., & Sinha, R. (2011). Emotion  
regulation and substance use frequency in women with substance dependence and 
borderline personality disorder receiving dialectical behavior therapy. The American 
Journal of Drug and Alcohol Abuse, 37(1), 37-42. 
Ball, J. S., & Links, P. S. (2009). Borderline personality disorder and childhood trauma: evidence  
for a causal relationship. Current Psychiatry Reports, 11(1), 63-68. 
Barlow, D. H., & Nock, M. K. (2009). Why can't we be more idiographic in our research?  
Perspectives on Psychological Science, 4(1), 19-21. 
Barnicot, K., Gonzalez, R., McCabe, R., & Priebe, S. (2016). Skills use and common treatment  
processes in dialectical behaviour therapy for borderline personality disorder. Journal of 
Behavior Therapy and Experimental Psychiatry, 52, 147-156. 
Barnicot K, Katsakou C, Marougka S, Priebe S. (2011). Treatment completion in psychotherapy  
for borderline personality disorder – a systematic review and meta-analysis. Acta  
Psychiatry Scandanavia, 123, 327-338.   
Barnett, A. G., van der Pols, J. C., & Dobson, A. J. (2005). Regression to the mean: What it is  
and how to deal with it. International Journal of Epidemiology, 34(1), 215–220 
Bedics, J., Atkins, D. C., Harned, M., Linehan, M. M. (2015). The therapeutic alliance as a  
predictor of outcome in dialectical behavior therapy versus nonbehavioral psychotherapy 




Berking, M., Neacsiu, A., Comtois, K. A., & Linehan, M. M. (2009). The impact of experiential  
avoidance on the reduction of depression in treatment for borderline personality disorder. 
Behaviour Research and Therapy, 47(8), 663-670. 
Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The  
posttraumatic stress disorder checklist for DSM‐5 (PCL‐5): Development and initial 
psychometric evaluation. Journal of Traumatic Stress, 28(6), 489-498. 
Bloom, J. M., Woodward, E. N., Susmaras, T., & Pantalone, D. W. (2012). Use of dialectical  
behavior therapy in inpatient treatment of borderline personality disorder: A systematic 
review. Psychiatric Services, 63(9), 881-888. 
Boelen, P. A., & Reijntjes, A. (2009). Intolerance of uncertainty and social anxiety. Journal of  
Bohus, M., Haaf, B., Simms, T., Limberger, M. F., Schmahl, C., Unckel, C., . . . Linehan,  
M. M. (2004). Effectiveness of inpatient dialectical behavioral therapy for borderline 
personality disorder: a controlled trial. Behaviour Research and Therapy, 42(5), 487-499. 
Anxiety Disorders, 23(1), 130-135. 
Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R. D., Domsalla, M., Chapman, A. L., ...  
& Wolf, M. (2009). The short version of the Borderline Symptom List (BSL-23): 
development and initial data on psychometric properties. Psychopathology, 42(1), 32-39. 
Bohus M., Limberger, M. F., Frank, U., Chapman, A. L., Kuehler, T., & Stieglitz, R. D. (2007).  
Psychometric properties of the Borderline Symptom List (BSL). Psychopathology, 40, 
126-132. 




R. D. (2011). Preliminary psychometric properties of the Acceptance and Action 
Questionnaire–II: A revised measure of psychological inflexibility and experiential 
avoidance. Behavior Therapy, 42(4), 676-688. 
Boswell, J. F., Thompson‐Hollands, J., Farchione, T. J., & Barlow, D. H. (2013). Intolerance of  
uncertainty: A common factor in the treatment of emotional disorders. Journal of Clinical 
Psychology, 69(6), 630-645. 
Bornovalova, M. A., Levy, R., Gratz, K. L., & Lejuez, C. W. (2010). Understanding the  
heterogeneity of BPD symptoms through latent class analysis: Initial results and clinical 
correlated among inner-city substance users. Psychological Assessment, 22(2), 233-245. 
Bowen, D. J., Kreuter, M., Spring, B., Cofta-Woerpel, L., Linnan, L., Weiner, D., … Fernandez,  
M. (2009). How we design feasibility studies. American Journal of Preventive Medicine, 
36(5), 452–457. 
Buhr, K., & Dugas, M. J. (2002). The intolerance of uncertainty scale: Psychometric properties  
of the English version. Behaviour Research and Therapy, 40(8), 931-945. 
Burleson, J. A., & Kaminer, Y. (2005). Self-efficacy as a predictor of treatment outcome in  
adolescent substance use disorders. Addictive Behaviors, 30(9), 1751-1764. 
Castro-Schilo, L, & Grimm, K. J. (2018). Using residualized change versus difference scores for  
longitudinal research. Journal of Social and Personal Relationships, 35(1), 32-58. 
Carleton, R. N., Collimore, K. C., & Asmundson, G. J. (2007). Social anxiety and fear of  
negative evaluation: Construct validity of the BFNE-II. Journal of Anxiety Disorders, 
21(1), 131-141. 




It’s that I don’t know: Intolerance of uncertainty as a predictor of social anxiety. Journal 
of Anxiety Disorders, 24, 189-195. 
Carleton, R. N., Mulvogue, M. K., Thibodeau, M. A., McCabe, R. E., Antony, M. M., &  
Asmundson, G. J. (2012). Increasingly certain about uncertainty: Intolerance of 
uncertainty across anxiety and depression. Journal of Anxiety Disorders, 26(3), 468-479. 
Carter, G. L., Willcox, C. H., Lewin, T. J., Conrad, A. M., & Bendit, N. (2010). Hunter  
DBT project: Randomized controlled trial of dialectical behaviour therapy in women with 
borderline personality disorder. Australian & New Zealand Journal of Psychiatry, 44(2), 
162-173. 
Cha, C.B., Tezanos, K.M., Peros, O.M., Ng, M.Y., Ribeiro, J.D., Nock, M.K., & Franklin, J.C.  
(2017). Accounting for diversity in suicide research: Sampling and sample reporting 
practices in the United States. Suicide and Life-Threatening Behavior. Advanced online 
publication. https://doi.org/10.1111/sltb.12344. 
Chanen, A. M., & McCutcheon, L. K. (2008). Personality disorder in adolescence: The diagnosis  
that dare not speak its name. Pers Ment Health, 2(1), 35–41. 
Chapman, A. L., Gratz, K. L., & Brown, M. Z. (2006). Solving the puzzle of deliberate self- 
harm: The experiential avoidance model. Behaviour Research and Therapy, 44, 371-394. 
Chawla, N., & Ostafin, B. (2007). Experiential avoidance as a functional dimensional approach  
to psychopathology: An empirical review. Journal of clinical psychology, 63(9), 871-890. 
Chen, E. Y., Matthews, L., Allen, C., Kuo, J. R., & Linehan, M. M. (2008). Dialectical behavior  
therapy for clients with binge-eating disorder or bulimia nervosa and borderline 
personality disorder. International Journal of Eating Disorders, 41(6), 505-512. 




Borderline personality disorder in young people and the prospects for prevention and 
early intervention. Current Psychiatry Reviews, 4(1), 48-57. 
Cohen, J. (1977). Statistical power analysis for the behavioral sciences. Routledge. 
Comer, J. S., Roy, A. K., Furr, J. M., Gotimer, K., Beidas, R. S., Dugas, M. J., & Kendall, P. C.  
(2009). The intolerance of uncertainty scale for children: A psychometric evaluation. 
Psychological Assessment, 21(3), 402-411. 
Connors, C., & Stalker, K. (2007). Children’s experiences of disability: Pointers to a social 
model of childhood disability. Disability and Society, 22(1), 19–33. 
Cronbach, L. J., & Furby, L. (1970). How should we measure “change”—or should we? 
Psychological Bulletin, 74, 68–80. 
Damschroder, L. J., Aron, D. C., Rosalind, K. E., Kirsh, S. R., Alexander, J. A., & Lowery, J.  
(2009). Fostering implementation of health services research findings into practice: A 
consolidated framework for advancing implementation science. Implementation Science, 
4(1), 50.  
Diamond, G., Creed, T., Gillham, J., Gallop, R., & Hamilton, J. L. (2012). Sexual trauma history  
does not moderate treatment outcome in attachment-based family therapy (ABFT) for 
adolescents with suicide ideation. Journal of Family Psychology, 26(4), 595. 
Diamond, G. S., Reis, B. F., Diamond, G. M., Siqueland, L., & Isaacs, L. (2002). Attachment- 
based family therapy for depressed adolescents: A treatment development study. Journal 
of the American Academy of Child & Adolescent Psychiatry, 41(10), 1190-1196.Dimeff,  
Dimeff, L. A., & Linehan, M. M. (2008). Dialectical behavior therapy for substance abusers.  
Addiction Science & Clinical Practice, 4(2), 39–47. 




substance abuse: A pilot application to methamphetamine-dependent women with 
borderline personality disorder. Cognitive and Behavioral Practice, 7(4), 457-468. 
Dockett, S., Perry, Bl., & Kearney, E. (2013). Promoting children’s informed assent in research  
participation. International Journal of Qualitative Studies in Education, 26(7), 802-828, 
Dugas, M. J., Buhr, K., & Ladouceur, R. (2004). The role of intolerance of uncertainty in the  
etiology and maintenance of generalized anxiety disorder. In: R. G. Heimberg, C. L. 
Turk, & D. S. Mennin (Eds.), Generalized anxiety disorder: advances in research and 
practice (pp. 143–163). New York: Guilford Press. 
Dugas, M. J., Gosselin, P., & Ladouceur, R. (2001). Intolerance of uncertainty and worry:  
Investigating specificity in a nonclinical sample. Cognitive Therapy and Research, 25(5), 
551-558. 
Endicott, J., Nee, J., Yang, R., & Wohlberg, C. (2006). Pediatric quality of life enjoyment and  
satisfaction questionnaire (PQ-LES-Q): reliability and validity. Journal of the American 
Academy of Child & Adolescent Psychiatry, 45(4), 401-407. 
Faul, F., Erdfelder, E., Lang, A., & Buchner, A. (2007). G*Power 3: A flexible statistical power  
analysis program for the social, behavioral, and biomedical sciences. Behavior Research 
Methods, 39(2), 175-191. 
Foa, E. B., & Rothbaum, B. O. (1998). Treating the trauma of rape: Cognitive behavioral 
therapy for PTSD. New York: Guilford Press. 
Fox, H. C., Axelrod, S. R., Paliwal, P., Sleeper, J., & Sinha, R. (2007). Difficulties in emotion  
regulation and impulse control during cocaine abstinence. Drug and Alcohol 
Dependence, 89(2-3), 298-301. 




Adolescent Medicine Clinics, 17(1), 233. 
Gentes, E. L., & Ruscio, A. M. (2011). A meta-analysis of the relation of intolerance of  
uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and 
obsessive–compulsive disorder. Clinical Psychology Review, 31(6), 923-933. 
Glenn, C. R., & Klonsky, E. D. (2009). Emotion dysregulation as a core feature of borderline  
 personality disorder. Journal of Personality Disorders, 23(1).  
Gottman, J. M., & Rushe, R. H. (1993). The analysis of change: Issues, fallacies, and new ideas. 
Journal of Consulting and Clinical Psychology, 61, 907–910. 
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., … Ruan, W. J.  
(2008). Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline 
Personality Disorder: Results from the Wave 2 National Epidemiologic Survey on 
Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 69(4), 533–545. 
Gratz, K. L., Levy, R., & Tull, M. T. (2012). Emotion regulation as a mechanism of change in an  
acceptance-based emotion regulation group therapy for deliberate self-harm among 
women with borderline personality pathology. Journal of Cognitive Psychotherapy, 
26(4), 365. 
Gratz, K. L., & Roemer, L. (2004). Multidimensional assessment of emotion regulation and  
dysregulation: Development, factor structure, and initial validation of the Difficulties in 
Emotion Regulation Scale. Journal of Psychopathology and Behavioral Assessment, 
26(1), 41-54. 
Groves, S. Backer, H., van den Bosch, W., & Miller. A. (2012). Review: Dialectical behaviour  
therapy with adolescents. Child and Adolescent Mental Health, 17(2), 65-75. 




and self-injuring women with borderline personality disorder: Development and 
preliminary evaluation of a Dialectical Behavior Therapy Prolonged Exposure 
protocol. Behaviour Research and Therapy, 50, 381-386.   
Hayes, S. C., Wilson, K. G., Gifford, E. V., Follette, V. M., & Strosahl, K. (1996). Experiential  
avoidance and behavioral disorders: A functional dimensional approach to diagnosis and 
treatment. Journal of Consulting and Clinical Psychology, 64(6), 1152. 
Heimberg, R. G., Horner, K. j., Juster, H. r., Safren, S. A., Brown, E. J., Schneier, F. R., &  
Liebowitz, M. R. (1999). Psychometric properties of the Liebowitz Social Anxiety Scale. 
Psychological Medicine, 29, 199-212. 
Hulbert, C., & Thomas, R. (2010). Predicting self-injury in BPD: an investigation of the  
experiential avoidance model. Journal of Personality Disorders, 24(5), 651-663. 
James, A. C., Taylor, A., Winmill, L., & Alfoadari, K. (2008). A preliminary community study  
of Dialectical Behavior Therapy (DBT) with adolescent females demonstrating persistent, 
deliberate self-harm (DSH). Child and Adolescent Mental Health, 13, 148-152. 
Jacobson, N. S., Follette, W. C., & Revenstorf, D. (1984). Psychotherapy outcome research:  
Methods for reporting variability and evaluating clinical significance. Behavior Therapy, 
15, 336-352. 
Jones, A. (2004). Involving children and young people as a researcher. In Doing research with 
children and young people, ed. S. Fraser, V. Lewis, S. Ding, M. Kellett, and C. Robinson, 
113–30. London: Routledge. 
Joormann, J., & Gotlib, I. H. (2010). Emotion Regulation in Depression: Relation to Cognitive  
Inhibition. Cognition & Emotion, 24(2), 281–298.  




Pediatrics, 134(4), 782-793. 
Kashdan, T. B., Barrios, V., Forsyth, J. P., & Steger, M. F. (2006). Experiential avoidance as a  
generalized psychological vulnerability: Comparisons with coping and emotion 
regulation strategies. Behaviour Research and Therapy, 44(9), 1301-1320. 
Katz, L. Y., & Cox, B. J. (2002). Dialectical Behavior Therapy for suicidal adolescent inpatients:  
A case study. Clinical Case Studies, 1(1), 81-92. 
Keshen, A., Helson, T., Town, J., & Warren, K. (2017). Self-efficacy as a predictor of treatment  
outcome in an outpatient eating disorder program. Eating Disorders, 25(5), 406-419. 
Koons, C. R., Robins, C. J., Tweed, J. L., Lynch, T. R., Gonzalez, A. M., Morse, J. Q., . .  
. Bastian, L. A. (2001). Efficacy of dialectical behavior therapy in women veterans with 
borderline personality disorder. Behavior Therapy, 32(2), 371-390. 
Kopala-Sibley, D. C., Zuroff, D. C., Russell, J. J., Moskowitz, D. S., & Paris, J. (2012).  
Understanding heterogeneity in borderline personality disorder: Differences in affective 
reactivity explained by the traits of dependency and self-criticism. Journal of Abnormal 
Psychology, 121(3), 680-691. 
Kröger, C., Harbeck, S., Armbrust, M., & Kliem, S. (2013). Effectiveness, response, and  
dropout of dialectical behavior therapy for borderline personality disorder in an inpatient 
setting. Behaviour Research and Therapy, 51(8), 411-416. 
Landes, S. J., Chalker, S. A., & Comtois, K. A. (2016). Predicting dropout in outpatient  
dialectical behavior therapy with patients with borderline personality disorder receiving 
psychiatric disability. Borderline Personality Disorder and Emotion Dysregulation, 3, 9.  




injury: A review of the literature on conceptualization and intervention. Trauma, 
Violence, & Abuse, 12(1), 23-37. 
Leary, M. R. (1983). A brief version of the Fear of Negative Evaluation Scale. Personality and  
Social Psychology Bulletin, 9, 371-375. 
Leon, A., Davis, L., & Kraemer, H. (2011). The role and interpretation of pilot studies in clinical  
research. Journal of Psychiatric Research., 45(5), 626.  
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997). Assessing psychiatric  
impairment in primary care with the Sheehan Disability Scale. The international journal 
of psychiatry in medicine, 27(2), 93-105. 
Linehan M. M. (1993a). Cognitive-Behavioral Treatment of Borderline Personality Disorder.  
New York: Guilford. 
Linehan M. M. (1993b). Skills Training Manual for Treating Borderline Personality Disorder.  
New York: Guilford. 
Linehan, M. (2014). DBT® skills training manual. Guilford Publications. 
Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., ...  
Lindenboim, N. (2006). Two-year randomized controlled trial and follow-up of 
dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline 
personality disorder. Archives of General Psychiatry, 63(7), 757-766. 
Linehan, M. M., Dimeff, L., Koerner, K., & Miga, E. M. (2014). Research on dialectical  
behavior therapy: Summary of the data to date. Retrieved from http://behavioraltech.org/ 
downloads/Research-on-DBT_Summary-of-Data-to-Date.pdf 




P., & Kivlahan, D. R. (2002). Dialectical behavior therapy versus comprehensive 
validation therapy plus 12-step for the treatment of opioid dependent women meeting 
criteria for borderline personality disorder. Drug & Alcohol Dependence, 67(1), 13-26. 
Linehan, M. M., Schmidt, H., Dimeff, L. A., Craft, J. C., Kanter, J., & Comtois, K. A.  
(1999). Dialectical behavior therapy for patients with borderline personality disorder and 
drug‐dependence. The American Journal on Addictions, 8(4), 279-292. 
Linehan, M. M., Suarez, A., & Allmon, D. (1991). Cognitive-Behavioral Treatment of  
Chronically. Archive of General Psychiatry, 48, 1060-1064. 
Lynch, T. R., Gray, K. L., Hempel, R. J., Titley, M., Chen, E. Y., & O’Mahen, H. A. (2013).  
Radically open-dialectical behavior therapy for adult anorexia nervosa: Feasibility and 
outcomes from an inpatient program. BMC Psychiatry, 13(1), 293. 
Lynch, T. R., Trost, W. T., Salsman, N., & Linehan, M. M. (2007). Dialectical behavior therapy  
for borderline personality disorder. Annual Review of Clinical Psychology, 3, 181-205. 
MacPherson, H. A., Cheavens, J. S., & Fristad, M. A. (2013). Dialectical Behavior Therapy for  
adolescents: Theory, treatment adaptations, and empirical outcomes. Clinical Child and 
Family Psychology Review, 16(1), 59-80. 
Mahoney, A. E., & McEvoy, P. M. (2012). A transdiagnostic examination of intolerance of  
uncertainty across anxiety and depressive disorders. Cognitive Behaviour Therapy, 41(3), 
212-222. 
Masia-Warner, C., Storch, E. A., Pincus, D. B., Klein, R. G., Heimberg, R. G., & Liebowitz, M.  
R. (2003). The Liebowitz social anxiety scale for children and adolescents: an initial 
psychometric investigation. Journal of the American Academy of Child & Adolescent 




McCredie, M. N., Quinn, C. A., & Covington, M. (2017). Dialectical behavior therapy in  
adolescent residential treatment: Outcomes and effectiveness. Residential Treatment for 
Children & Youth, 34(2), 84-106. 
McDonell, M. G., Tarantino, J., Dubose, A. P., Matestic, P., Steinmetz, K., Galbreath, H., &  
McClellan J. M. (2010). A pilot evaluation of dialectical behavioural therapy in 
adolescent long-term inpatient care. Child and Adolescent Mental Health, 15(4), 193-196 
McEvoy, P., & Mahoney, A. (2012). To Be Sure, To Be Sure: Intolerance of uncertainty  
mediates symptoms of various anxiety disorders and depression. Behavior Therapy, 
43(3), 533-545. 
McHugh, R. K., & Barlow, D. H. (2010). The dissemination and implementation of evidence- 
based psychological treatments: a review of current efforts. American Psychologist, 
65(2), 73. 
McKenzie, K. C., & Gross, J. J. (2014). Nonsuicidal self-injury: An emotion regulation  
perspective. Psychopathology, 47(4), 207-219. 
McMain, S. F., Fitzpatrick, S., Boritz, T., Barnhart, R., Links, P., & Streiner, D. L. (2017).  
Outcome trajectories and prognostic factors for suicide and self-harm behaviors in 
patients with borderline personality disorder following one year of outpatient 
psychotherapy. Journal of Personality Disorders, 1-16. 
McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J., Korman, L., & Streiner,  
D. L. (2009). A randomized trial of dialectical behavior therapy versus general 
psychiatric management for borderline personality disorder. American Journal of 
Psychiatry, 166(12), 1365-1374. 




adolescent partial hospital program. Journal of Child and Adolescent Psychiatric 
Nursing, 4, 207-218. 
Mennin, D. S., Heimberg, R. G., Turk, C. L., & Fresco, D. M. (2002). Applying an emotion  
regulation framework to integrative approaches to generalized anxiety disorder. Clinical 
Psychology: Science and Practice, 9(1), 85-90. 
Miller, A. L. (1999). Dialectical Behavior Therapy: A new treatment approach for suicidal  
adolescents. American Journal of Psychotherapy, 53, 413-417. 
Miller, A. L., Muehlenkamp, J. J., & Jacobson, C. M. (2008). Fact or fiction: Diagnosing  
borderline personality disorder in adolescents. Clinical Psychology Review, 28(6), 969-
981. 
Miller, A. L., Rathus, J. H., Linehan, M. M. Wetzler, S., & Leigh, E. (1997). Dialectical  
Behavior Therapy adapted for suicidal adolescents. Journal of Practical Psychiatry and 
Behavioral Health, 3, 78-86. 
Neacsiu, A. D., Eberle, J. W., Kramer, R., Wiesmann, T., & Linehan, M. M. (2014). Dialectical  
behavior therapy skills for transdiagnostic emotion dysregulation: A pilot randomized 
controlled trial. Behaviour Research and Therapy, 59, 40-51. 
Neumann, A., van Lier, P. A. C., Gratz, K. L., & Koot, H. M. (2010). Multidimensional  
assessment of emotion regulation difficulties in adolescents using the difficulties in 
emotion regulation scale. Assessment, 17(1), 138-149.  
Nock, M.K., Borges, G., Bromet, E., Cha, C.B., Kessler, R.C., & Lee, S. (2008). Suicide and  
suicidal behavior. Epidemiologic Reviews, 30, 133–154. 




borderline personality disorder and posttraumatic stress disorder in the U.S. population. 
Journal of Psychiatric Research, 44, 1190–1198. 
Palmer, R. L., Birchall, H., Damani, S., Gatward, N., McGrain, L., & Parker, L. (2003). A  
dialectical behavior therapy program for people with an eating disorder and borderline 
personality disorder -- description and outcome. International Journal of Eating 
Disorders, 33(3), 281-286. 
Panos, P. T., Jackson, J. W., Hasan, O., & Panos, A. (2014). Meta-analysis and systematic  
review assessing the efficacy of dialectical behavior therapy (DBT). Research on Social 
Work Practice, 24(2), 213-223. 
Perez, J., Venta, A., Garnaat, C. S. (2012). The Difficulties in Emotion Regulation Scale: Factor  
structure and association with nonsuicidal self-injury in adolescent inpatients. Journal of 
Psychopathol Behav Assess, 34, 393-404.  
Perroud, N., Uher, R., Dieben, K., Nicastro, R., & Huguelet, P. (2010). Predictors of response  
and drop-out during intensive dialectical behavior therapy. Journal of Personality 
Disorders, 24, 634-650. 
Rathus, J. H., & Miller, A. L. (2000). DBT for adolescents: Dialectical dilemmas and secondary  
treatment targets. Cognitive and Behavioral Practice, 7, 425-434. 
Rathus, J. H., & Miller, A. L. (2002). Dialectical Behavior Therapy adapted for suicidal  
adolescents. Suicide Life Threatening Behaviors, 32, 146-157. 
Raymond, C. (1983). "The clinical use of difference scores: Some psychometric problems."  
Multivariate Experimental Clinical Research, 6(2), 87. 
Ritschel, L., Lim, N. E., & Stewart, L. M. (2015). Transdiagnostic applications of DBT for  




Rizvi, S. L. (2011). Treatment failure in dialectical behavior therapy. Cognitive and Behavioral  
Practice, 18, 403-412. 
Robins, C. J., & Chapman, A. L. (2004). Dialectical Behavior Therapy: Current status, recent  
developments, and future directions. Journal of Personality Disorders, 18(1), 73-89. 
Rogosa, D. W., & Willett, J. B. (1983). Demonstrating the reliability of the difference score in  
the measurement of change. Journal of Education Measurement, 20, 335–343. 
Rosenthal, M. Z., Hall, M. L. R., Palm, K. M., Batten, S. V., & Follette, V. M. (2005). Chronic  
avoidance helps explain the relationship between severity of childhood sexual abuse and 
psychological distress in adulthood. Journal of Child Sexual Abuse, 14(4), 25-41. 
Ruggiero, K. J., Del Ben, K., Scotti, J. R., & Rabalais, A. E. (2003). Psychometric properties of  
the PTSD Checklist—Civilian version. Journal of Traumatic Stress, 16(5), 495-502. 
Rüsch, N., Schiel, S., Corrigan, P., Leihener, F., Jacob, G., Olschewski, M., . . . Bohus,  
M. (2008). Predictors of dropout from inpatient dialectical behavior therapy among 
women with borderline personality disorder. Journal of Behavior Therapy and 
Experimental Psychiatry, 39(4), 497-503. 
Rush, A. J., Trivedi, M., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., . . . Keller, M.  
B. (2003). The 16-item quick inventory of depressive symptomatology (QIDS), clinician 
rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with 
chronic major depression. Biological Psychiatry, 54(5), 573-583. 
Safer, D. L., Telch, C. F., & Agras, W. S. (2001). Dialectical behavior therapy for bulimia  
nervosa. American Journal of Psychiatry, 158(4), 632-634. 




history. [Last accessed on 2019 June 10]. Available from: http://www.iupui.edu/ 
~histwhs/ G504.dir/irbhist.html. 
Sheehan , D. V. ( 1986 ). The anxiety disease . New York: Bantam. Leon , A. C., Olfson , M.,  
Portera , L., Farber , L., & Sheehan , D. V. (1997). Assessing psychiatric impairment in 
primary care with the Sheehan Disability Scale. International Journal of Psychiatry in 
Medicine, 27, 93 – 105. 
Sheehan , K. H. , & Sheehan , D. V. ( 2008 ). Assessing treatment effects in clinical trials with  
 the discan metric of the Sheehan Disability Scale. International Clinical  
Psychopharmacology, 23, 70 – 83. 
Shore, N., Brazauskas, R., Drew, E., Wong, K. A., Moy, L., Baden, A. C., . . . Seifer, S. D.  
(2011). Understanding community-based processes for research ethics review: A national 
study. American Journal of Public Health, 101, S359-S364. 
Soler, J., Trujols, J., Pascual, J. C., Portella, M. J., Barrachina, J., Campins, J., ... & Pérez, V.  
(2008). Stages of change in dialectical behaviour therapy for borderline personality 
disorder. British Journal of Clinical Psychology, 47(4), 417-426. 
Stangier, U., Heidenreich, T., Peitz, M., Lauterbach, W., & Clark, D. M. (2003). Cognitive  
therapy for social phobia: individual versus group treatment. Behaviour Research and 
Therapy, 41(9), 991-1007. 
Steil, R., Dyer, A., Priebe, K., Kleindienst, N., & Bohus, M. (2011). Dialectical behavior therapy  
for posttraumatic stress disorder related to childhood sexual abuse: a pilot study of an 
intensive residential treatment program. Journal of Traumatic Stress, 24(1), 102-106. 




cognitive–emotional aspects of intolerance of uncertainty in eating disorder patients. 
Journal of Anxiety Disorders, 25(6), 806-812. 
Steuwe, C., Berg, M., Driessen, M., & Beblo, T. (2017). Impact of therapist change after initial  
contact and traumatic burden on dropout in a naturalistic sample of inpatients with 
borderline pathology receiving dialectical behavior therapy. Borderline Personality  
Disorder and Emotion Dysregulation 4, 14. 
Swenson, C. R., Sanderson, C., Dulit, R., & Linehan, M. M. (2001). The application of  
Dialectical Behavior Therapy for patients with borderline personality disorder on 
inpatient units. Psychiatric Quarterly, 72(4), 307-324. 
Telch, C. F., Agras, W. S., & Linehan, M. M. (2001). Dialectical behavior therapy for binge  
eating disorder. Journal of Consulting and Clinical Psychology, 69(6), 1061-1074. 
Thompson, R. A. (1994). Emotion regulation: A theme in search of definition. Society for  
Research in Child Development, 59(2), 25-52. 
Thompson, B. L., & Waltz, J. (2010). Mindfulness and experiential avoidance as predictors of  
posttraumatic stress disorder avoidance symptom severity. Journal of Anxiety Disorders, 
24(4), 409-415. 
Tull, M. T., Barrett, H. M., McMillan, E. S., & Roemer, L. (2007). A preliminary investigation  
of the relationship between emotion regulation difficulties and posttraumatic stress 
symptoms. Behavior Therapy, 38(3), 303-313. 
Twenge, J. M., Joiner, T. E., Rogers, M. L., & Martin, G. N. (2018). Increases in depressive  
symptoms, suicide-related outcomes, and suicide rates among US adolescents after 2010 
and links to increased new media screen time. Clinical Psychological Science, 6(1), 3-17. 




Den Brink, W. (2003). Dialectical behaviour therapy for women with borderline 
personality disorder: 12-month, randomised clinical trial in The Netherlands. The British 
Journal of Psychiatry, 182(2), 135-140. 
Vitiello, B. (2003). Ethical considerations in psychopharmacological research involving children 
and adolescents. Psychopharmacology, 171(1), 86–91. 
Wasser, T., Tyler. R., McIlhaney, K., Taplin, R., & Henderson, L. (2008). Effectiveness of  
dialectical behavior therapy (DBT) versus standard therapeutic milieu (STM) in a cohort 
of adolescents receiving residential treatment. Best Practices in Mental Health, 4(2), 114-
125. 
Weinberg, A., & Klonsky, E. D. (2009). Measurement of emotion dysregulation in adolescents.  
Psychological Assessment, 21(4), 616-621. 
Whiteside, S. P. (2009). Adapting the Sheehan Disability Scale to assess child and parent  
impairment related to childhood anxiety disorders. Journal of Clinical Child & 
Adolescent Psychology, 38(5), 721-730. 
Whittaker, J. K., Holmes, L., del Valle, J. F., Ainsworth, F., Andreassen, T., Anglin, J., . . .   
Courtney, M. (2016). Therapeutic residential care for children and youth: A consensus 
statement of the international work group on therapeutic residential care. Residential 
Treatment for Children & Youth, 33(2), 89-106. 
Wilhelm, S., & Steketee, G. S. (2006). Cognitive therapy for obsessive compulsive disorder: A  
guide for professionals. New Harbinger Publications. 
Williams, R. H., & Zimmerman, D. W. (1996). Are simple gain scores obsolete? Applied  
Psychological Measurement, 20(1), 59-69. 




adolescents and their families in a community outpatient clinic. Cognitive and Behavioral 
Practice, 34, 15–25. 
Wright, K., Lebell, M., & Carleton, R. (2016). Intolerance of uncertainty, anxiety sensitivity,  
health anxiety, and anxiety disorder symptoms in youth. Journal of Anxiety Disorders., 
41, 35-42. 
Yook, K., Kim, K. H., Suh, S. Y., & Lee, K. S. (2010). Intolerance of uncertainty, worry, and  
rumination in major depressive disorder and generalized anxiety disorder. Journal of 






Table 1. Means and standard deviations of study measures.  
Predictor Variables Pre Post 
   Mean SD Mean SD 
DERS      
 Nonacceptance 19.91 6.05 12.21 5.24 
 Goals  19.72 4.19 13.94 5.32 
 Impulse  17.31 5.97 9.57 3.6 
 Aware  20.61 4.74 13.64 5.55 
 Strategies  28.83 6.89 16.81 7.4 
 Clarity  16.85 4.23 11.51 4.07 
 Total  123.48 21.56 77.45 26.38 
BFNE      
 Total  39.07 5.20 30.25 4.57 
PCL-5      
 Total  43.62 18.09 21.33 13.80 
IUSC      
 Total  86.09 20.20 63.73 22.00 
AAQ-II      
 Total  19.27 7.53 37.17 9.37 
       
Outcome Measures Pre Post 
   Mean SD Mean SD 
BSL-23      
 Total  2.18 0.85 1.03 0.81 
QIDS      
 Total  16.57 4.59 7.91 5.02 
PQ-LES-Q      
  Total   45.93 14.24 68.86 15.59 
Note. DERS = Difficulty of Emotions Regulation Scale; BFNE = 
Brief Fear of Negative Evaluation Scale; PCL-5 = PTSD 
Checklist for DSM-5; IUSC = Intolerance of Uncertainty Scale for 
Children; AAQ-II = Acceptance and Action Questionnaire-II; 
BSL-23 = Borderline Symptom List; QIDS = Quick Inventory of 
Depressive Symptomatology; PQ-LES-Q = Pediatric Quality of 
Life Enjoyment and Satisfaction Questionnaire. 
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Measures F b t R
2
p
DERS-36 Total F(1, 89) = .01 0.01 0.09 < .01 0.93
BFNE Total F(1, 9) = .01 -0.02 -0.07 < .01 0.95
PCL-5 Total F(1, 19) = .05 0.05 0.23 < .01 0.82
AAQ-II Total F(1, 5) = 2.89 0.61 1.70 0.37 0.15
IUSC Total F(1, 89) = 2.98 0.18 1.73 0.03 0.09
DERS-36 Total F(1, 89) = .72 -0.09 -0.85 < .01 0.40
BFNE Total F(1, 9) = .20 0.15 0.45 0.02 0.66
PCL-5 Total F(1, 19) = .01 0.02 0.08 < .01 0.94
AAQ-II Total F(1, 5) = 1.37 0.46 1.17 0.22 0.30
IUSC Total F(1, 89) = .97 0.12 1.16 0.02 0.25
DERS-36 Total F(1, 89) = 1.19 0.12 1.09 0.01 0.28
BFNE Total F(1, 9) = .82 0.29 0.91 0.08 0.39
PCL-5 Total F(1, 19) = .13 0.08 0.36 < .01 0.72
AAQ-II Total F(1, 5) = 2.28 -0.56 -1.51 0.31 0.19
IUSC Total F(1, 89) = 1.88 -0.14 -0.137 0.02 0.17
Table 2. Independent linear regression analyses with BSL-23, QIDS, and PQ-LES-Q 
residual change scores regressed onto predictor variables. 
DV = BSL-23 residualized 
change scores.
DV = QIDS residualized 
change scores.
DV = PQ-LES-Q 
residualized change scores.
Note. DERS-36 = Difficutlies in Emotion Regulation Scale; BFNE = Brief Fear of 
Negative Events Scale; PCL-5 = PTSD Checklist for DSM-5; IUSC = Intolerance of 
Uncertainty Scale for Children; AAQ-II = Acceptance and Action Questionnaire-II; BSL-
23 = Borderline Symptom List; QIDS = Quick Inventory of Depressive Symptomatology; 



























1 1 1 0 50 1 1 0
2 1 -1 -1 51 0 0 0
3 1 1 0 52 1 1 0
4 0 0 0 53 1 1 0
5 0 0 0 54 1 1 1
6 0 0 0 55 1 1 0
7 1 -1 0 56 0 0 0
8 0 0 0 57 1 1 1
9 0 0 0 59 1 1 0
10 1 1 0 60 1 1 1
11 0 0 0 61 0 0 0
12 0 0 0 62 1 1 0
13 1 1 0 64 1 1 0
14 1 1 0 65 0 0 0
15 0 0 0 67 0 0 0
16 1 1 0 68 1 1 0
17 1 1 0 69 1 1 1
18 0 0 0 70 1 1 1
19 1 1 1 72 0 0 0
21 1 1 0 73 0 0 0
22 0 0 0 74 1 1 1
23 0 0 0 75 1 1 0
24 0 0 0 76 1 1 0
25 1 1 0 77 1 1 1
26 1 1 0 79 0 0 0
27 1 1 0 80 1 1 0
28 0 0 0 81 1 1 1
29 0 0 0 82 0 0 0
30 1 1 0 83 0 0 0
31 0 0 0 84 1 1 1
32 0 0 0 85 1 1 1
33 1 1 0 86 0 0 0
34 1 1 1 87 1 1 1
35 1 1 1 88 0 0 0
36 1 1 0 89 0 0 0
37 0 0 0 90 1 1 1
38 1 1 1 91 1 -1 0
40 1 1 1 92 0 0 0
42 0 0 0 93 1 1 0
43 1 1 0 94 0 0 0
44 1 1 1 95 1 1 1
45 0 0 0 96 0 0 0
46 0 0 0 98 1 1 0
47 1 1 0 99 1 1 1
48 0 0 0 100 0 0 0
49 1 1 1 104 1 1 1
RC = 54, No RC = 38; RCI = 51, No RCI = 38, Deteriorated = 3; CSC = 22, No CSC = 67, Deteriorated = 3.
Table 3. RC, RCI, and CSC status for each resident. Total represents the sum of absolute values.
Note . RC = reliable change;  No RC = no reliable change. RCI = met relaible change index threshold for 
improvement; No RCI = did not meet reliable change index threshold for improvement; Deteriorated = met 






Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
BSL-23 (n = 92)
Total 52.23 12.05 6.55 3.02 47.94 21.08 27.45 16.40 39.00 3.00 67.67 15.28
QIDS (n  = 92)
Total 16.41 4.17 3.59 1.56 16.27 4.86 8.94 4.67 18.50 0.71 18.00 4.58
PQ-LES-Q (n  = 92)
Total 45.83 15.49 84.58 8.17 46.51 14.39 65.06 13.19 43.75 3.79 41.67 11.89
DERS-36 (n  = 92)
Nonacceptance 20.27 4.88 7.77 1.85 19.88 6.46 13.18 4.70 20.00 2.00 23.67 6.51
Goals 19.64 4.38 9.23 4.28 19.31 4.25 15.09 4.80 19.33 1.16 20.00 1.73
Impulse 18.14 6.95 6.41 0.59 16.33 5.25 10.27 3.49 22.33 2.31 16.00 2.00
Awareness 21.82 5.15 8.68 2.27 20.30 4.44 14.93 8.68 18.00 2.65 20.00 4.36
Strategies 29.50 4.74 10.14 2.05 28.01 7.50 18.27 6.78 31.00 2.65 33.00 3.00
Clarity 17.00 3.19 7.23 1.77 16.55 4.34 12.64 3.70 15.67 1.15 16.00 2.65
Total 126.36 16.96 49.45 8.91 120.39 21.52 84.37 22.74 126.33 10.02 128.67 2.52
BFNE (n = 7)
Total 39.25 3.59 31.00 1.41 38.57 6.21 23.00 1.41 - - - -
PCL-5 (n  = 21)
Total 46.88 12.62 12.45 9.10 40.23 21.54 26.94 11.93 - - - -
AAQ-II (n  = 7)
Total 16.33 8.33 45.00 3.16 23.25 8.66 33.25 9.00 - - - -
IUSC (n  = 91)
Total 83.64 15.50 43.86 9.68 85.91 21.18 68.52 21.07 79.50 17.68 91.00 12.53
Note. CSC = clinically significant change; No CSC = no clinically signficiant change; Deterioration = clinically significant change 
toward deterioration; DERS-36 = Difficutlies in Emotion Regulation Scale; BFNE = Brief Fear of Negative Events Scale; PCL-5 = 
PTSD Checklist for DSM-5; IUSC = Intolerance of Uncertainty Scale for Children; AAQ-II = Acceptance and Action Questionnaire-
II; BSL-23 = Borderline Symptom List; QIDS = Quick Inventory of Depressive Symptomatology; PQ-LES-Q = Pediatric Quality of 
LIfe Enjoyment and Satisfaction Questionnaire.
Table 4. Means and standard deviations of pre and post scores of residents who showed CSC, No CSC, or Deterioration.
Clinically Significant Change 
(n  = 22)
No Clinically Significant Change 
(n  = 67)
PostPre
Deteriorated 














DERS (n  = 92)
Total 0.01 0.01 1.33 0.25 1.01 0.02 0.02
DERS (n = 92) 0.05 0.07
Nonacceptance <.01 0.05 <.01 0.99 1.00
Goals -0.07 0.08 0.64 0.42 0.94
Impulse 0.06 0.06 1.31 0.25 1.07
Awareness 0.10 0.06 2.58 0.11 1.11
Strategies 0.03 0.06 0.29 0.59 1.03
Clarity -0.05 0.08 0.37 0.45 0.95
BFNE (n  = 7)
Total 0.03 0.13 0.05 0.83 1.03 <.01 0.01
PCL-5 (n  = 8)
Total 0.02 0.03 0.65 0.42 1.02 0.03 0.04
AAQ-II (n  = 4)
Total -0.13 0.12 1.10 0.29 0.88 0.18 0.24
IUSC (n  = 91)
Total -0.01 0.01 0.19 0.66 1.00 <.01 <.01
Table 5. Independent binary logistic regression with CSC group classification as the criterion variable 
(CSC, No CSC), and pre-treatment scores of clinical measures as the predictor variable.
Note. CSC = clinically significant change; No CSC = no clinically signficiant change; Deterioration = 
clinically significant change toward deterioration; DERS-36 = Difficutlies in Emotion Regulation 
Scale; BFNE = Brief Fear of Negative Events Scale; PCL-5 = PTSD Checklist for DSM-5; IUSC = 
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